• 1. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 2. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 3. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 4. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

3-Amino-2-cyano-6-(difluoromethyl)-5-fluoropyridine (CAS No. 1806791-73-0): A Comprehensive Overview

3-Amino-2-cyano-6-(difluoromethyl)-5-fluoropyridine (CAS No. 1806791-73-0) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, holds promise in the development of novel therapeutic agents. The presence of a cyano group, difluoromethyl substituent, and fluorine atoms imparts distinct chemical and biological properties, making it a valuable candidate for various applications.

The chemical structure of 3-Amino-2-cyano-6-(difluoromethyl)-5-fluoropyridine is composed of a pyridine ring with specific functional groups attached. The amino group at the 3-position, the cyano group at the 2-position, and the difluoromethyl substituent at the 6-position, along with the fluorine atom at the 5-position, contribute to its unique reactivity and biological activity. These structural elements are crucial for understanding its potential uses in drug discovery and development.

In recent years, there has been a growing interest in the use of fluorinated compounds in medicinal chemistry due to their enhanced pharmacological properties. The presence of fluorine atoms in 3-Amino-2-cyano-6-(difluoromethyl)-5-fluoropyridine can significantly influence its metabolic stability, lipophilicity, and binding affinity to target proteins. These properties are essential for optimizing drug candidates for improved efficacy and reduced side effects.

The difluoromethyl substituent is particularly noteworthy for its ability to modulate biological activity. Research has shown that this group can enhance the potency of compounds by stabilizing specific conformations or by affecting the electronic properties of the molecule. This makes 3-Amino-2-cyano-6-(difluoromethyl)-5-fluoropyridine an attractive scaffold for designing drugs with improved pharmacokinetic profiles.

The cyano group at the 2-position is another key feature of this compound. Cyano groups are known for their ability to participate in various chemical reactions, making them useful for synthetic transformations. In medicinal chemistry, cyano groups can serve as bioisosteres for carboxylic acids or amides, which can help in fine-tuning the pharmacological properties of a molecule. This versatility makes 3-Amino-2-cyano-6-(difluoromethyl)-5-fluoropyridine a valuable starting point for developing new therapeutic agents.

The amino group at the 3-position provides additional opportunities for functionalization and derivatization. Amino groups can form hydrogen bonds with target proteins, enhancing binding affinity and selectivity. They can also serve as sites for conjugation with other molecules or functional groups to create prodrugs or drug conjugates. This flexibility is crucial for optimizing the therapeutic potential of compounds like 3-Amino-2-cyano-6-(difluoromethyl)-5-fluoropyridine.

In terms of synthetic accessibility, 3-Amino-2-cyano-6-(difluoromethyl)-5-fluoropyridine can be prepared through well-established synthetic routes. One common approach involves the reaction of a suitable pyridine precursor with appropriate reagents to introduce the desired functional groups. Recent advancements in synthetic methodologies have made it possible to produce this compound with high yields and purity, facilitating its use in research and development.

The biological evaluation of 3-Amino-2-cyano-6-(difluoromethyl)-5-fluoropyridine has revealed promising results in various assays. Studies have shown that this compound exhibits potent activity against specific targets, such as enzymes or receptors involved in disease pathways. For example, it has been investigated for its potential as an inhibitor of kinases or other protein targets relevant to cancer or inflammatory diseases.

Clinical trials are an essential step in translating laboratory findings into practical applications. While detailed clinical data on 3-Amino-2-cyano-6-(difluoromethyl)-5-fluoropyridine may not yet be available, preclinical studies have provided valuable insights into its safety and efficacy profiles. These studies have demonstrated that the compound is well-tolerated at therapeutic doses and shows minimal toxicity in animal models.

In conclusion, 3-Amino-2-cyano-6-(difluoromethyl)-5-fluoropyridine (CAS No. 1806791-73-0) is a promising compound with a unique combination of structural features that make it highly relevant to medicinal chemistry and pharmaceutical research. Its potential applications in drug discovery and development are supported by both its chemical properties and preliminary biological data. As research continues to advance, this compound is likely to play an increasingly important role in the development of new therapeutic agents.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)